The study medication is a type of antibiotic. It is specially designed to remain in the body for a longer period of time and has activity against bacteria resistant to other antibiotics commonly used to treat UTI.
Participants will be randomly assigned to receive either the study medication or an approved antibacterial medication called amoxicillin/clavulanate. Both medications are taken by mouth.
Yes. The study medication has been used by more than 1,800 people in other clinical research studies. The study medication is not approved by regulatory authorities like the US Food and Drug Administration (FDA), and it can only be used in clinical research studies like IT001-310.